Diätetische und medikamentöse Therapie des Kurzdarmsyndroms

O. Leiß

doi:10.1055/s-2005-857923

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2005; 43(7): 661-675
DOI: 10.1055/s-2005-857923

Übersicht

Diätetische und medikamentöse Therapie des Kurzdarmsyndroms

Clinical Management of Patients with Short Bowel SyndromeO. Leiß¹

¹Gastroenterologische Gemeinschaftspraxis PD Dr. N. Börner; Dr. Th. Clement, Dr. W. Gödderz, Dr. H.-J. Schreiber, Dr. A. Lutz-Vorderbrügge, Prof. Dr. O. Leiß, Bahnhofsplatz 2, 55116 Mainz

Abstract

Zusammenfassung

Durchfälle, Malabsorption und Mangelernährung sind die Hauptsymptome des Kurzdarmsyndroms. Die zugrunde liegenden gastrointestinalen Erkrankungen, die typischerweise durchgeführten Darmresektionen und die daraus folgenden pathophysiologischen Konsequenzen werden zusammenfassend dargestellt. Die therapeutischen Maßnahmen in der postoperativen Phase und in der Langzeitrehabilitation von Patienten mit Kurzdarmsyndrom werden ausführlich erörtert. Die initiale parenterale Ernährung soll frühzeitig durch eine enterale Ernährung ergänzt werden, um die intestinale Adaptation zu begünstigen, den Flüssigkeitsverlust zu reduzieren und die Nährstoffresorption zu verbessern. Die langfristigen diätetischen Maßnahmen hängen von der Art der durchgeführten Operation und vom Vorhandensein eines Dickdarms ab. Die Bedeutung des Dickdarms als Verdauungsorgan und Energielieferant und die Notwendigkeit einer oxalatarmen Ernährung werden herausgestellt. Der mögliche Nutzen neuerer Therapieoptionen (Glutamin, Wachstumshormon, Glukagon-like Peptid 2) wird erörtert. Typische Krankheitskomplikationen des Kurzdarmsyndroms und Möglichkeiten ihrer Behandlung werden dargestellt.

Abstract

Diarrhoea, malabsorption and malnutrition characterise the short bowel syndrome. The underlying gastrointestinal disorders, the types of intestinal resections performed and the subsequent pathophysiological situations are reviewed. Recommended therapeutic measures in the postoperative period as well as in the rehabilitation of patients with short bowel syndrome are discussed in more detail. In the postoperative period, parenteral nutrition is essential followed by an enteral diet to stimulate bowel adaptation, reduce fluid loss and increase nutrient absorption. The final diet should be based on the anatomy of the retained bowel (presence or absence of a colon and ileum). The importance of the colon as a digestive organ in patients with short bowel and the need of a low-oxalate diet are underlined. The possible benefit of new treatment options (glutamine, growth hormone and glucagon-like peptide 2) is discussed. Both typical complications of the short bowel syndrome and management of these complications are presented.

Schlüsselwörter

Kurzdarmsyndrom - Jejunostomie - jejunokolische Anastomose - diätetische Therapie - parenterale Ernährung - Glutamin - Wachstumshormon

Key words

Short bowel syndrome - jejunostomy - jejunocolonic anastomosis - diet therapy - parenteral nutrition - glutamine - growth hormone

Full Text

References

Literatur

1 Lennard-Jones J E. Review article: practical management of the short bowel. Aliment Pharmacol. 1994; 8 563-577
2 Brasitus T A, Sitrin M D. Short bowel syndrome. Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE Textbook of Gastroenterology Philadelphia; Lippincott Company 1991: 1541-1554
3 Vanderhoof J A, Langnas A N. Short-bowel syndrome in children and adults. Gastroenterology. 1997; 113 1767-1778
4 Scopalio J S, Fleming C R. Short bowel syndrom. Gastroenterology Clinics of North America. 1998; 27 467-479
5 Wilmore D W, Byrne T A. Approach to the patient with short-bowel syndrome. Wolfe MM Therapy of Digestive Disorders - A Companion to Sleisenger and Fordtran’s Gastrointestinal and Liver Disease Philadelphia, London, Toronto; W.B. Saunders Company 2000: 557-564
6 Malik A, Westergaard H. Short Bowel Syndrome. Feldman M, Friedman LS, Sleisenger MH Sleisenger & Fordtran’s Gastrointestinal and Liver Disease - Pathophysiology/Diagnosis/Management. 7th edition Philadelphia, London, New York; W.B. Saunders Company 2002: 1807-1816
7 American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology. 2003; 124 1105-1110
8 AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003; 124 1111-1134
9 Schwartz M Z, Maeda K. Short bowel syndrome in infants and children. Pediatr Clin North Am. 1985; 32 1265-1269
10 Nightingale J M, Bartram C I, Lennard-Jones J E. Length of residual small bowel after partial resection: Correlation between radiographic and surgical measurements. Gastrointestinal Radiology. 1991; 16 305-306
11 Jeppesen P B, Mortensen P B. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut. 2000; 46 401-407
12 Jeppesen P B, Mortensen P B. Experimental approaches: dietary and hormone therapy. Best Practice & Research Clinical Gastroenterology. 2003; 17 1041-1054
13 Farrell J J. Digestion and absorption of nutrients and vitamins. Feldman M, Friedman LS, Sleisenger MH Sleisenger & Fordtran’s Gastrointestinal and Liver Disease - Pathophysiology/Diagnosis/Management. 7th edition Philadelphia, London, New York; W.B. Saunders Company 2002: 1715-1750
14 Högenauer C, Hammer H F. Maldigestion and malabsorption. Feldman M, Friedman LS, Sleisenger MH Sleisenger & Fordtran’s Gastrointestinal and Liver Disease - Pathophysiology/Diagnosis/Management. 7th edition Philadelphia, London, New York; W.B. Saunders Company 2002: 1751-1782
15 Steinhardt H J. Therapie des Kurzdarmsyndroms. DMW. 1987; 112 1139-1141
16 Nightingale J MD, Lennard-Jones J E, Walker E R. et al . Jejunal efflux in short bowel syndrome. Lancet. 1990; 336 765-768
17 Woolf G M, Miller C, Kurian R. et al . Nutritional absorption in short bowel syndrome. Evaluation of fluid, calorie, and divalent cation requirements. Dig Dis Sci. 1987; 32 8-15
18 Williamson R CN. Intestinal adaption: Structural, functional, and cytokinetic changes. N Engl J Med 1978; 298: 1393 - 1402 and Williamson RCN. Intestinal adaption: Mechanisms of control. N Engl J Med. 1978; 298 1444-1450
19 Cosnes J, Carbonel F, Beaugerie L. et al . Functional adaption after extensive small bowel resection in humans. Eur J Gastroenterol Hepatol. 1994; 6 197-202
20 Thompson J S. Can the intestine adapt to a changing environment?. Gastroenterology. 1997; 113 1402-1405
21 Thiesen A Jr, Drozdowski L, Iordache C. et al . Adaption following intestinal resection: mechanisms and signals. Best Practice & Research Clinical Gastroenterology. 2003; 17 981-995
22 Laurenco R. Enteral feeding: Drug/nutrient interaction. Clin Nutr. 2001; 20 187-193
23 AGA technical review on parenteral nutrition. Gastroenterology. 2001; 121 970-1001
24 Cartot A, Fleming C R, Malagelada J R. Improved nutrient absorption in short-bowel syndrome with gastric hypersecretion. N Engl J Med. 1979; 300 79-81
25 Jacobsen O, Ladefoged K, Stage J G. et al . Effects of cimetidine on jejunostomy effluents in patients with severe short bowel syndrome. Scand J Gastroenterol. 1986; 21 824-828
26 Nightingale J MD, Walker E R, Farthing M JG. et al . Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther. 1991; 5 405-412
27 Beier-Holgersen R. The importance of early postoperative enteral feeding. Clin Nutr. 2001; 20 (Supplement 1) 123-127
28 Senkal M. Perioperative Ernährung. Löser C, Keymling M Praxis der enteralen Ernährung. Indikationen - Technik - Nachsorge Stuttgart, New York; Georg Thieme Verlag 2001: 148-158
29 Bengmark S, Andersson R, Mangiante G. Uninterrupted perioperative enteral nutrition. Clin Nutr. 2001; 20 11-19
30 Rodrigues C A, Lennard-Jones J E, Walker E R. et al . The effects of octreotide, soy polysaccharide, codein and loperamide on nutrient, fluid and electrolyte absorption in the short bowel syndrome. Aliment Pharmacol Ther. 1989; 3 159-169
31 O’Keefe S JD, Haymond M W, Bennet W M. et al . Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology. 1994; 107 379-388
32 Thompson J S, Nguyen B LT, Harty R F. Somatostatin analogue inhibits intestinal regeneration. Arch Surg. 1993; 128 385-389
33 Ecker K W, Stallmach, Seitz G. et al . Oral budesonide significantly improves water absorption in patients with ileostomy for Crohn disease. Scand J Gastroenterol. 2003; 38 288-293
34 Rothstein R D, Rombeau J L. Nutrient pharmacotherapy for gut mucosal diseases. Gastroenterology Clinics of North America. 1998; 27 387-401
35 Wilmore D W. Indications for specific therapy in the rehabilitation of patients with the short bowel syndrome. Best Practice & Research Clinical Gastroenterology. 2003; 17 895-906
36 Jenkins A P, Thompson R PH. Enteral nutrition and the small intestine. Gut. 1994; 35 1765-1769
37 AGA technical review on tube feeding for enteral nutrition. Gastroenterology. 1995; 108 1282-1301
38 DeWitt R C, Kudsk K A. Enteral nutrition. Gastroenterology Clinics of North America. 1998; 27 371-386
39 Suchner U, Felbinger T W. Enterale, minimal enterale, parenterale Ernährung - Vorteile einer enteralen Ernährungsstrategie. Löser C, Keymling M Praxis der enteralen Ernährung. Indikationen - Technik - Nachsorge Stuttgart, New York; Georg Thieme Verlag 2001: 32-40
40 Vanderhoof J A, Young R J. Enteral and parenteral nutrition in the care of patients with short-bowel syndrome. Best Practice & Research Clinical Gastroenterology. 2003; 17 997-1015
41 Beale J R, Bryg D J, Bihari D J. Immunonutrition in the critically ill: A systematic review of clinical outcome. Crit Care Med. 1999; 27 2799-2805
42 Suchner U, Felbinger T W. Enterale Immunonutrition. Löser C, Keymling M Praxis der enteralen Ernährung. Indikationen - Technik - Nachsorge Stuttgart, New York; Georg Thieme Verlag 2001: 20-31
43 Ziegler T R, Evans M E, Fernandez-Estivariz C. et al . Trophic and cytoprotective nutrition for intestinal adaption, mucosal repair, and barrier function. Annu Rev Nutr. 2003; 23 229-261
44 Pita A M, Wakabayashi Y, Fernandez-Bustos M A. et al . Plasma urea-cycle-related amino acids, ammonium levels, and urinary orotic acid excretion in short-bowel patients managed with an oral diet. Clin Nutr. 2003; 22 93-98
45 Soeters P B, van de Poll M CG, van Gemert W G. et al . Amino acid adequacy in pathophysiological states. J Nutr. 2004; 134 1575S-1582S
46 Sundaram A, Koutkia P, Apovian C M. Nutritional management of short bowel syndrome. J Clin Gastroenterol. 2002; 34 207-220
47 Tremel H, Kienle B, Weilemann L S. et al . Glutamine-dipeptide supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology. 1994; 107 1595-1601
48 Scolapio J S, McGreevy K, Tennyson G S. et al . Effect of glutamine in short-bowel syndrome. Clin Nutr. 2001; 20 319-323
49 Byrne T A, Persinger R L, Young L S. et al . A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Annals of Surgery. 1995; 222 243-254
50 Byrne T A, Morrissay T B, Nattakom T V. et al . Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr. 1995; 19 296-302
51 Scolapio J S, Camilleri M C, Fleming C R. Effect of growth hormone, glutamine, and diet on adaption in short bowel syndrome: A randomized controlled study. Gastroenterology. 1997; 113 1074-1081
52 Ellegard L, Bosaeus I, Nordgren S. et al . Low dose growth hormone recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg. 1997; 225 88-96
53 Scolapio J S. Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled trial. JPEN. 1999; 23 309-312
54 Skudlarek J, Jeppesen P B, Mortensen P B. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double blind, crossover, placebo controlled study. Gut. 2000; 47 199-205
55 Seguy D, Vahedi K, Kapel N. et al . Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology. 2003; 124 293-302
56 Jeppesen P B, Hartman B, Thulesen J. et al . Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short bowel patients with no colon. Gastroenterology. 2001; 120 806-815
57 Scolapio J S. Tales from the crypt (editorial). Gastroenterology. 2003; 124 561-564
58 Schroth H J, Berberich R, Feifel G. et al . Tests for the absorption of (75-Se-HCAT) Tauro-23-Selenium-25 Homocholic acid. Eur J Nucl Med. 1985; 10 455-457
59 Berberich R. Intestinal absorption tests. Biersack H, Cox PH Nuclear Medicine in Gastroenterology Dordrecht, Boston, London; Kluwer Academic Publishers 1991: 191-199
60 Bengmark S. Use of some pre-, pro- and synbiotics in critically ill patients. Best Practice & Research Clinical Gastroenterology. 2003; 17 833-848
61 Gill H S. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Practice & Research Clinical Gastroenterology. 2003; 17 755-773
62 Reid C, Jass J, Sebuldsky M T. et al . Potential use of probiotics in clinical practice. Clin Microbiol Rev. 2003; 16 658-672
63 Jeppesen P B, Mortensen P B. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut. 1998; 43 478-483
64 Nightingale J MD, Kamm M A, van der Sijp JRM. et al . Disturbed gastric emptying in the short bowel syndrome. Evidence for a ‘colonic brake’. Gut. 1993; 34 1171-1176
65 Nightingale J MD, Kamm M A, van der Sijp JRM. et al . Gastrointestinal hormones in the short bowel syndrome. PYY may be the ‘colonic brake’ to gastric emptying. Gut. 1996; 39 267-272
66 Gregg C R, Toskes P P. Enteric bacterial flora and small bowel bacterial overgrowth syndrome. Feldman M, Friedman LS, Sleisenger MH Sleisenger & Fordtran’s Gastrointestinal and Liver Disease - Pathophysiology/Diagnosis/Management. 7th edition Philadelphia, London, New York; W.B. Saunders Company 2002: 1783-1793
67 Messing B, Pigot F, Rongier M. et al . Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology. 1991; 100 1991-1997
68 Anderson H, Isaksson B, Sjogren B. Fat-reduced diet in the symptomatic treatment of small bowel disease. Gut. 1974; 15 351-359
69 Woolf G M, Miller C, Kurian R. et al . Diet for patients with short bowel: High fat or high carbohydrate?. Gastroenterology. 1983; 84 823-828
70 Gruy-Kapral C, Little K H, Fordtran J S. et al . Conjugated bile acid replacement therapy for short-bowel syndrome. Gastroenterology. 1999; 116 15-21
71 Heydorn S, Jeppesen P B, Mortensen P B. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastroenterol. 1999; 34 818-823
72 Kapral C, Wewalka F, Praxmarer V. et al . Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon. Z Gastroenterol. 2004; 42 583-589
73 Bond J H, Currier B E, Buchwald H. et al . Colonic conservation of malabsorbed carbohydrate. Gastroenterology. 1980; 78 444-447
74 Nightingale J MD, Lennard-Jones J E, Gertner D J. et al . Colonic preservation reduces the need for parenteral therapy, increases the incidence of renal stones but does not change the high prevalence of gallstones in patients with a short bowel. Gut. 1992; 33 1493-1497
75 Nordgaard I, Hansen B S, Mortensen P B. Colon as a digestive organ in patients with short bowel. Lancet. 1994; 343 373-376
76 Jeppesen P B, Mortensen P B. Significance of a preserved colon for parenteral energy requirements in patients receiving home parenteral nutrition. Scand J Gastroenterol. 1998; 33 1175-1179
77 Marteau P, Messing B, Arrigoni E. et al . Do patients with short-bowel syndrome need a lactose-free diet?. Nutrition. 1997; 13 13-16
78 Miranda S C, Ribeiro M L, Ferriolli E. et al . Hypomagnesemia in short bowel syndrome patients. Sao Paulo Med J. 2000; 118 169-72
79 Lindberg J S, Zobitz M M, Poindexter J R. et al . Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr. 1990; 9 48-55
80 Ross J R, Dargan P I, Jones A L. et al . A case of hypomagnesaemia due to malabsorption, unresponsive to oral administration of magnesium glycerophosphate, but responsive to oral magnesium oxide supplementation. Gut. 2001; 48 857-858
81 McIntyre P B, Fitches M, Lennard-Jones J E. Patients with a high jejunostomy do not need a special diet. Gastroenterology. 1986; 91 25-33
82 Müller J M, Keller H W, Brenner U. et al . Die ambulante parenterale Dauer-ernährung bei Kranken mit Kurzdarm-Syndrom. Internist. 1984; 25 292-298
83 Messing B, Lemann M, Landais P. et al . Prognosis of patients with non-malignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology. 1995; 108 1005-1010
84 Howard L, Hassan N. Home parenteral nutrition - 25 years later. Gastroenterology Clinics of North America. 1998; 27 481-512
85 Messing B, Crenn P, Beau P. et al . Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999; 117 1043-1050
86 van Gossum A, Vahedi K, Abdel-Malik M. et al . Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre survey. Clin Nutr. 2001; 20 205-210
87 Carbonnel F, Cosnes J, Chevret S. et al . The role of anatomic factors in nutritional autonomy after extensive small bowel resection. J Parent Enter Nutr. 1996; 20 275-280
88 Byrne T A, Cox S, Karimbakas M. et al . Bowel rehabilitation: An alternative to long-term parenteral nutrition and intestinal transplantation for some patients with short bowel syndrome. Transplantation Proceedings. 2002; 34 887-890
89 Howard L, Ashley C. Management of complications in patients receiving home parenteral nutrition. Gastroenterology. 2003; 124 1651-1661
90 Grant D. Current results of intestinal transplantation. Lancet. 1996; 347 1801-1803
91 Benedetti E, Panaro F, Holterman M. et al . Surgical approaches and intestinal transplantation. Best Practice & Research Clinical Gastroenterology. 2003; 17 1017-1040
92 Quigley E MM, Marsh M N, Shaffer J L. et al . Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993; 104 286-301
93 Nightingale J MD. Hepatobiliary, renal and bone complications of intestinal failure. Best Practice & Research Clinical Gastroenterology. 2003; 17 907-929
94 Chan S, McCoven K S, Bistrain B R. et al . Incidence, prognosis, and etiology of end stage liver disease in patients receiving home total parenteral nutrition. Surgery. 1999; 126 28-34
95 Cavicchi M, Beau P, Crenn P. et al . Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132 525-532
96 Hwang T L, Lue M C, Chen L L. Early use of cyclic TPN prevents further deterioration of liver functions for the TNP patients with impaired liver function. Hepatogastroenterology. 2000; 47 1347-1350
97 Spagnuolo M I, Iorio R, Vegnente A. et al . Ursodeoxycholic acid for the treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology. 1996; 111 716-719
98 Bolondi L, Gaiani S, Testa S. et al . Gall bladder sludge formation during prolonged fasting after gastrointestinal tract surgery. Gut. 1985; 26 734-738
99 Messing B, Bories C, Kuntslinger F. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?. Gastroenterology. 1983; 84 1012-1019
100 Lee S P, Maher K, Nicholls J F. Origin and fate of biliary sludge. Gastroenterology. 1988; 94 170-176
101 Ko C W, Sekijima J H, Lee S P. Biliary Sludge. Ann Intern Med. 1999; 130 301-311
102 Dowling H R, Hussaini S H, Murphy G M. et al . Gallstones during octreotide therapy. Metabolism. 1992; 41 (Suppl 2) 22-33
103 Redfern J S, Fortuner W J II. Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management. Am J Gastroenterol. 1995; 90 1042-1052
104 Veysey M J, Thomas L A, Mallet A I. et al . Colonic transit influences deoxycholic acid kinetics. Gastroenterology. 2001; 121 812-822
105 Oh M S, Phelps K R, Traube M. et al . D-Lactic acidosis in a man with the short bowel syndrome. N Engl J Med. 1979; 301 249-252
106 Shike M, Harrison J E, Sturtridge W C. et al . Metabolic bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med. 1980; 92 343-350
107 Pironi L, Labate A M, Pertkiewicz M. et al . Prevalence of bone disease in patients on home parenteral nutrition. Clin Nutr. 2002; 21 289-296
108 Reimund J -M, Arondel Y, Finck G. et al . Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey. Clin Nutr. 2002; 21 33-38
109 Santarpia L, Pasanisi F, Alfonsi L. et al . Prevention and treatment of central venous catheter (CVC)-related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr. 2002; 21 207-211
110 Mermel L A. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000; 132 391-402
111 Capdevila J A. How to manage central venous catheter-related sepsis. Clin Nutr. 2002; 21 195-197
112 Winkler R. Leben mit Stoma. Winkler R Stomatherapie - Atlas und Leitfaden für intestinale Stomata. 3. Auflage Stuttgart; Georg Thieme Verlag 1993: 96-102
113 Carlsson E, Bosaeus I, Nordgren S. What concerns subjects with inflammatory bowel disease and an ileostomy?. Scand J Gastroenterol. 2003; 38 978-984

Prof. Dr. med. Ottmar Leiß

Internist/Gastroenterologe

Bodelschwinghstraße 14

65191 Wiesbaden

Phone: 06 11/50 37 65

Fax: 06 11/9 50 56 13

Email: OLeiss@aol.com